Published on Medical Design Technology (http://www.mdtmag.com)

Home > New England Biolabs, Sequenom form licensing deal

New England Biolabs, Sequenom form licensing deal

Mass High Tech: The Journal of New England Technology

New England Biolabs Inc. (NEB) has signed a licensing and co-marketing deal with Sequenom Inc. to commercialize the EpiMark Methylated DNA Enrichment Kit.

The epigenetics product is created from intellectual property rights related to the University of Regensburg, Germany, and acquired by Sequenom. The EpiMark Methylated DNA Enrichment Kit’s analysis of methylated regions could be used in non-invasive prenatal diagnostics, the companies reported.

SOURCE [1]

Source URL (retrieved on 05/24/2013 - 11:46am): http://www.mdtmag.com/news/2011/04/new-england-biolabs-sequenom-form-licensing-deal

Links:
[1] http://www.masshightech.com/stories/2011/04/04/daily32-New-England-Biolabs-Sequenom-form-licensing-deal.html